BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Vapotherm Inc. Announces Approval in Canada for New High Flow Device Designed for Heliox


7/14/2011 7:13:13 AM

Vapotherm Announces Approval in Canada for New High Flow Device Designed for Heliox

PR Newswire

STEVENSVILLE, Md., July 13, 2011 /PRNewswire-USNewswire/ -- Vapotherm, a privately held manufacturer of respiratory care devices for hospital and home use, announced today that it has received approval from the Medical Device Bureau of Health Canada for the Precision Flow® Heliox device which will be launched later this year in the Canadian hospital market. The device is part of Vapotherm's High Flow Specialty Gas Program.

"We are pleased to receive our license in Canada for Precision Flow® Heliox, the first high flow device specifically designed for heliox delivery, said Bill Niland, Chairman and Director of New Business Development at Vapotherm." The Company has also submitted for 510(k) clearance of the device in the U.S. and is also submitting for CE marking for other international markets.

Vapotherm's High Flow Specialty Gas Program was created to expand High Flow Therapy (HFT) beyond air and oxygen to other medical and specialty gases. The Company's flagship platform device, the Precision Flow®, was developed with a modular design concept to allow for several specialty applications in neonatal, pediatric and adult patient populations. In all applications, the device optimizes the delivery of gases via precise blending, flow control and temperature management. As with all Vapotherm HFT products, the overall goal is non-invasive respiratory support via a simple nasal cannula in a device that is easy for clinicians to operate but comprehensive in terms of safety and performance features. The Company plans to announce additional modules in the coming weeks.

Vapotherm, Inc. is a privately held manufacturer of respiratory care devices for hospitals and home care use based in Stevensville, Maryland. The Company is dedicated to the development of innovative, noninvasive technologies for respiratory therapy, especially for the treatment of chronic lung and acute breathing disorders. For more information, visit www.vtherm.com.

Contact: Kevin Thibodeau, Executive Vice President of Sales and Marketing
410-604-3977

SOURCE Vapotherm, Inc.



Read at BioSpace.com
Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES